Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04936607 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

ImproviNg rEnal Outcomes Following Coronary angiograPhy and/or percuTaneoUs coroNary intErventions

Study acronym: NEPTUNE
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv6
  2. Primary completion date: Jun 30, 2023 to Jan 30, 2027
    • Study completion date: Dec 31, 2023 to Jul 31, 2027
    • Collaborators: 1 to 2
    v5
  3. Re-verified, no change to tracked fieldsv4
  4. Lead sponsor: Guillaume Marquis-Gravel to Montreal Heart Institutev3
  5. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Jun 18, 2021 to Jun 28, 2021
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The NEPTUNE triple-blind, active-placebo, adaptive, pragmatic, randomized trial aims to evaluate the effectiveness of a new intra-venous hydration strategy guided by left ventricular end-diastolic pressure (LVEDP), amount of contrast used, and baseline renal function, to prevent contrast-induced acute kidney injury (CI-AKI) and patient-oriented clinical endpoints in all-comer patients undergoing coronary angiogram and/or percutaneous coronary intervention (PCI).
Trial Details
NCT Number NCT04936607
Lead Sponsor Montreal Heart Institute
Collaborators: Université de Montréal, Canadian Institutes of Health Research (CIHR)
Conditions
(from sponsor)		 Contrast-Induced Acute Kidney Injury
Related terms Acute Kidney Injury
Enrollment 1,158 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov